<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE collection SYSTEM "BioC.dtd"><collection><source>PMC</source><date>20180513</date><key>pmc.key</key>
<document><id>9586773</id><infon key="license">CC BY</infon><passage><infon key="article-id_doi">10.1155/2022/7137401</infon><infon key="article-id_pmc">9586773</infon><infon key="elocation-id">7137401</infon><infon key="license">This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</infon><infon key="name_0">surname:Cui;given-names:Yujuan</infon><infon key="name_1">surname:Zhang;given-names:Liangjun</infon><infon key="name_2">surname:Hu;given-names:Dandong</infon><infon key="name_3">surname:Yang;given-names:Yingli</infon><infon key="section_type">TITLE</infon><infon key="type">front</infon><infon key="volume">2022</infon><infon key="year">2022</infon><offset>0</offset><text>Berberine Inhibits Herpes Simplex Virus 1 Replication in HEK293T Cells</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract</infon><offset>71</offset><text>Berberine exhibits polytrophic medicinal roles in various diseases and is safe and effective. However, its role and the underlying mechanism in the replication of herpes simplex virus 1 (HSV-1) remain unreported. This research aimed to determine the functional mechanisms of berberine on HSV-1 infection. We determined the CC50 (405.11 +- 15.67 muM) and IC50 (45.6 +- 6.84 muM) of berberine on HEK293T cells infected with HSV-1. Berberine inhibited the transcription and translation of HSV-1 activity-related genes (gD, ICP-4, ICP-5, and ICP-8) in HSV-1-infected HEK293T cells dose-dependently. Berberine also inhibited the phosphorylation of MAPK proteins (JNK and p38) and inflammatory responses induced by HSV-1 infection in HEK293T cells dose-dependently. In conclusion, berberine attenuates HSV-1 replication through its activity, infective ability, and inflammatory response. Our research indicated that berberine may be a candidate drug for HSV-1 infection.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">title_1</infon><offset>1040</offset><text>1. Introduction</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>1056</offset><text>Herpes simplex virus (HSV) is a virus with double-stranded DNA under an envelope structure. HSV usually infects the body through the mucous membranes, skin, nerve tissue, and other related lesions. It has two serum subsets, HSV-1 and HSV-2. Infection with HSV-1 mainly leads to pharyngitis, cold sores, and keratitis and in severe cases will cause sporadic encephalitis and other dangerous diseases. HSV-2 mainly invades through damaged skin and mucous membranes to cause genital herpes. Immediate early gene (alpha gene), early gene (beta gene), and late gene (gamma gene) express after HSV-1-infected host cells. Infection cell protein (ICP4) expression peaks 2~4 hours after infection. The expression of the beta gene requires activation of alpha gene products. ICP5 and ICP8 can regulate viral DNA replication and participate in gamma gene transcription. Glycoprotein D (gD) is a late protein encoded by the gamma gene peaking 12~15 hours after infection, which is the main component of the virus envelope and helps the virus to absorb and enter the host cell. All these indicators can be used to evaluate the activity of HSV-1. Berberine is an alkaloid in the protoberberine group that existed in Berberidaceae, Papaveraceae, and Ranunculaceae.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>2306</offset><text>Berberine shows polytrophic medicinal effects, including anti-inflammatory, antibacterial, and antifungal. Berberine acts on a series of signaling pathways to improve diabetes. Several in vitro studies have found that berberine diminishes the proliferation, migration, and metastasis of cancer cells and accelerates apoptosis. It has been found that berberine promotes apoptosis by activating ROS-related signals, such as the JNK/p38 signaling pathway. ROS can activate JNK/p38 that block antiapoptotic protein Bcl-XL expression to release cytochrome C and stimulate caspases. Recently, berberine shows antiviral properties against influenza A virus (IAV), respiratory syncytial virus (RSV), chikungunya virus (CHIKV), enterovirus 71 (EV71,, human papillomavirus (HPV), and herpes simplex 55 virus (HSV), but its roles in HSV-1 infection is still unknown.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>3162</offset><text>Here, we aimed to explore the antiviral and anti-inflammatory impact of berberine in HSV-1-infected HEK293T cells. It was reported that berberine can dose-dependently reduce the activity of HSV-1 and HSV-1-induced secretion of inflammatory factors and the phosphorylation of p38 and JNK.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_1</infon><offset>3450</offset><text>2. Material and Methods</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>3474</offset><text>2.1. Material</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_3</infon><offset>3488</offset><text>2.1.1. Cells</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>3501</offset><text>HEK293T cells were obtained from Fudan University (Shanghai, China) and kept in DMEM (Roche, Basel, Switzerland) plus 1% antibiotics and 10% FBS (Solarbio, Beijing, China) under a humid incubator containing 5% CO2 at 37 C.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_3</infon><offset>3725</offset><text>2.1.2. Drugs and Cell Treatments</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>3758</offset><text>Berberine was purchased from Solarbio (Beijing, China, purity &gt;=98%). HEK293T cells were grouped: control group, cells were untreated; HSV group, infected with 200 pfu/well HSV; HSV+5 muM group, treated with 5 muM berberine and 200 pfu/well HSV; HSV+10 muM group, treated with 10 muM berberine and 200 pfu/well HSV; HSV+15 muM group, treated with 15 muM berberine and 200 pfu/well HSV. Following 24-h culture, HEK293T cells were applied to plaque reduction assay, RT-qPCR, western blot, and ELISA.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_1</infon><offset>4269</offset><text>3. Methods</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>4280</offset><text>3.1. Cytotoxicity Assay</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>4304</offset><text>The cytotoxicity of berberine on HEK293T cells was determined based on the CCK-8 assay. The minimum berberine concentration required to produce a toxic effect on 50% of HEK293T cells (CC50) was calculated by regression analysis of the dose-response curve.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>4560</offset><text>3.2. Plaque Reduction Assay</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>4588</offset><text>The anti-HSV-1 ability of berberine was evaluated (Jung et al., 2011). In detail, HEK293T cells (1 x 105/well) were cultured in a 24-well plate and treated with a corresponding dose of HSV-1 or berberine for 24 h. DMEM was added with 1% methylcellulose solution and 2% FCS (Solarbio, Beijing, China). Then, HEK293T cells were cultured under 5% CO2 at 37 C for 72 h. Monolayer cells were fixed and stained with 1% crystal violet, and formative plaques were counted. Finally, the minimum berberine concentration required to inhibit the 50% cytopathic effect (IC50) was calculated by regression analysis of the dose-response curve. The selectivity index (SI) was calculated by CC50/IC50.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>5279</offset><text>3.3. RT-qPCR</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>5292</offset><text>RNA was isolated using TRIzol (Takara, Liaoning, China), and cDNA was obtained with M-MLV Reverse Transcriptase (RNase H) kit (Takara, Liaoning, China). RT-qPCR was performed according to the previous report.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>5501</offset><text>3.4. ELISA</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>5512</offset><text>Following treatment with corresponding doses of HSV-1 or berberine for 24 h, 1 mL of extraction solution (Beyotime, Nanjing, China) was used to lyse HEK293T cells. Subsequently, the levels of inflammatory factors in the supernatant were determined with ELISA kits (Roche, Basel, Switzerland).</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>5809</offset><text>3.5. Western Blot</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>5827</offset><text>Proteins were obtained using Cell Lysis Buffer (Beyotime, Nanjing, China). Western blot was executed based on the previous description. The primary antibodies were ordered from Roche (Basel, Switzerland 1 : 1000) and goat-anti-rabbit IgG secondary antibody was the secondary antibody (Santa Cruz, San Francisco, USA, 1 : 2000). OD was quantified by Image J (Image J Inc.).</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>6208</offset><text>3.6. Statistical Analysis</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>6234</offset><text>Data were presented as the mean +- SD of three independent experiments and processed by GraphPad 5.0 (GraphPad Software, Inc.). Student's t-test or one-way ANOVA plus Tukey post hoc tests were conducted. P &lt; 0.05 indicated statistical significance.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_1</infon><offset>6483</offset><text>4. Results</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_2</infon><offset>6494</offset><text>4.1. Berberine Antagonizes HSV-1 Infection in HEK293T Cells</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>6554</offset><text>Berberine's chemical structure formula was analyzed (Figure 1(a)), and CCK-8 assay was conducted to explore berberine cytotoxicity on HEK293T cells. The CC50 of berberine on HEK293T cells was calculated to be 405.11 +- 15.67 muM, according to the regression analysis of the dose-response curve generated by CCK-8 assay (Figure 1(b)). In Figure 1(c), the IC50 of berberine on HEK293T cell infected with HSV-1 was 45.6 +- 6.84 muM based on plaque reduction assay. The decrease in HSV-1 plaque formation caused by the increase in berberine concentration was dose-related, indicating that berberine could inhibit HSV-1 infection of HEK293T cells. The selective index (SI) was 7.43-10.86 (in Figure 1(d)).</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_2</infon><offset>7267</offset><text>4.2. Berberine Decreases HSV-1 Activity in HEK293T Cells</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>7324</offset><text>To further analyze the effects of berberine on HSV-1 activity in HEK293T cells, RT-qPCR and western blot analyses were followed to assess the levels of HSV-1 infection-related genes, including g D, ICP-4, ICP-5, and ICP-8. RT-qPCR manifested that HSV-1 upregulated the transcription of the four HSV-1 infection-related genes, relative to the control group (P &lt; 0.01), while berberine antagonized this upregulation effect dose-dependently compared with the HSV group (Figure 2(a); P &lt; 0.05). Consistently, HSV infection promoted g D, ICP-4, ICP-5, and ICP-8 protein expression, whereas berberine antagonized this promotion dose-dependently (Figure 2(b); P &lt; 0.05). Taken together, berberine deceased HSV-1 activity in HEK293T cells.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_2</infon><offset>8056</offset><text>4.3. Berberine Inhibits JNK and p38 Activation Induced by HSV-1 Infection</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>8130</offset><text>It has been revealed that HSV-1 activated the MAPK pathway. To further explore the effect of HSV-1 on the MAPK pathway, the phosphorylation levels of MAPK-related proteins (JNK and p38) in HEK293T cells were assessed. Results showed that HSV-1 infection upregulates the phosphorylation levels of JNK (P &lt; 0.01) and p38 (P &lt; 0.001) proteins. Besides, further investigation indicated that berberine inhibited the HSV-1 infection-induced phosphorylation levels of JNK and p38 in HEK293T cells dose-dependently (P &lt; 0.05; Figure 3). Collectively, berberine inhibited JNK and p38 activation in HSV-1-treated HEK293T cells.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_2</infon><offset>8748</offset><text>4.4. Berberine Decreases Inflammatory Responses Induced by HSV-1 Infection</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>8823</offset><text>HSV-1 triggers inflammatory responses, such as gingival stomatitis, cold sores, keratitis, and meningitis. To investigate the effect of berberine on inflammatory responses caused by HSV-1, RT-qPCR and ELISA were conducted. Our results showed that HSV-1 infection upregulated the mRNA and secretion levels of cytokines (P &lt; 0.05) and berberine dose-dependently downregulated their levels triggered by HSV-1 infection (P &lt; 0.05; Figures 4(a) and 4(b)). Taken together, berberine inhibited inflammatory responses induced by HSV-1 infection in HEK293T cells.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">title_1</infon><offset>9378</offset><text>5. Discussion</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>9392</offset><text>Herpesviruses develop latency or cause oral and genital herpes, conjunctivitis, eczema herpeticum, and other diseases in 90% of the population. Herpesvirus also disturbs AIDS treatment under HIV infection. It is important to seek drug candidates against HSV-1. Here, it was proved that berberine antagonized HSV-1 activity, inflammatory responses, and MAPK pathway activation in HEK293T cells which may contribute to the inhibition of HSV-1.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>9834</offset><text>Berberine is cytotoxic to mast cells, rat hepatocytes, and Vero cells. Cytotoxicity is a factor that must be considered in seeking a candidate for HSV-1 treatment. A study showed that berberine exerted an anticancer impact against HeLa cells with CC50 of 12.08 mug/mL whereas exhibited low toxicity (CC50: 71.14 mug/mL) on normal Vero cells. Chin et al. found that the CC50 of berberine extracted from Coptis chinensis on Vero cells was 392.5 muM, the IC50 was 66.49 muM, and the SI was 5.9. Our results found that berberine could effectively inhibit HSV-1 activity (IC50: 45.6 +- 6.84 muM) in HEK293T cells and was with low toxicity (CC50: 405.11 +- 15.67 muM). The SI was 7.43-10.86, indicating berberine is a relatively safe and effective candidate for HSV-1 inhibition in vitro.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>10629</offset><text>Our study found that HSV-1 infection upregulates the phosphorylation levels of JNK and p38 proteins, which was similar to other's reports. MAPK pathway activation was stimulated by HSV-1 infection. Berberine was illustrated to reduce the phosphorylation levels of JNK and p38 MAPK under CVB3 infection. Zeng et al. illuminated the mechanism of berberine weakened host components JNK-MAPK, ERK-MAPK, and p38-MAPK activation. Li et al. found that berberine retarded IL-33-stimulated cytokine production in RPMCs. It has been demonstrated that the levels of ROS-related factors were boosted under IL-1beta treatment and pretreatment of berberine exhibited inhibitory roles. Besides, the decrease in inflammatory responses indicated that berberine diminished the HSV-1 infection-caused inflammation.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>11425</offset><text>In conclusion, our study showed that berberine inhibited HSV-1 replication by downregulation of HSV-1 activity, inflammatory responses, and MAPK pathway activation in HEK293T cells. Berberine may be a potential candidate for the treatment of HSV-1 infection.</text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">title_1</infon><offset>11684</offset><text>Data Availability</text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">paragraph</infon><offset>11702</offset><text>The data supporting the manuscript's conclusions will be made available to any qualified researcher without reservation.</text></passage><passage><infon key="section_type">COMP_INT</infon><infon key="type">title_1</infon><offset>11823</offset><text>Conflicts of Interest</text></passage><passage><infon key="section_type">COMP_INT</infon><infon key="type">paragraph</infon><offset>11845</offset><text>There are no conflicts of interest to declare.</text></passage><passage><infon key="fpage">399</infon><infon key="issue">2</infon><infon key="lpage">410</infon><infon key="name_0">surname:Debono;given-names:A. J.</infon><infon key="name_1">surname:Mistry;given-names:S. J.</infon><infon key="name_2">surname:Xie;given-names:J.</infon><infon key="pub-id_doi">10.1002/cmdc.201300395</infon><infon key="pub-id_other">2-s2.0-84897024163</infon><infon key="pub-id_pmid">24339417</infon><infon key="section_type">REF</infon><infon key="source"> ChemMedChem </infon><infon key="type">ref</infon><infon key="volume">9</infon><infon key="year">2014</infon><offset>11892</offset><text>The synthesis and biological evaluation of multifunctionalised derivatives of noscapine as cytotoxic agents</text></passage><passage><infon key="fpage">729</infon><infon key="issue">4</infon><infon key="lpage">735</infon><infon key="name_0">surname:Coleman;given-names:J. L.</infon><infon key="name_1">surname:Shukla;given-names:D.</infon><infon key="pub-id_doi">10.4161/hv.23289</infon><infon key="pub-id_other">2-s2.0-84877138314</infon><infon key="pub-id_pmid">23442925</infon><infon key="section_type">REF</infon><infon key="source"> Human Vaccines &amp; Immunotherapeutics </infon><infon key="type">ref</infon><infon key="volume">9</infon><infon key="year">2013</infon><offset>12000</offset><text>Recent advances in vaccine development for herpes simplex virus types I and II</text></passage><passage><infon key="fpage">27</infon><infon key="lpage">38</infon><infon key="name_0">surname:Chen;given-names:D.</infon><infon key="name_1">surname:Su;given-names:A.</infon><infon key="name_2">surname:Fu;given-names:Y.</infon><infon key="pub-id_doi">10.1016/j.antiviral.2015.09.003</infon><infon key="pub-id_other">2-s2.0-84941283161</infon><infon key="pub-id_pmid">26348003</infon><infon key="section_type">REF</infon><infon key="source"> Antiviral Research </infon><infon key="type">ref</infon><infon key="volume">123</infon><infon key="year">2015</infon><offset>12079</offset><text>Harmine blocks herpes simplex virus infection through downregulating cellular NF-kappaB and MAPK pathways induced by oxidative stress</text></passage><passage><infon key="fpage">6825</infon><infon key="issue">12</infon><infon key="lpage">6834</infon><infon key="name_0">surname:Bryant;given-names:K. F.</infon><infon key="name_1">surname:Yan;given-names:Z.</infon><infon key="name_2">surname:Dreyfus;given-names:D. H.</infon><infon key="name_3">surname:Knipe;given-names:D. M.</infon><infon key="pub-id_doi">10.1128/JVI.00374-12</infon><infon key="pub-id_other">2-s2.0-84864015508</infon><infon key="pub-id_pmid">22491472</infon><infon key="section_type">REF</infon><infon key="source"> Journal of Virology </infon><infon key="type">ref</infon><infon key="volume">86</infon><infon key="year">2012</infon><offset>12213</offset><text>Identification of a divalent metal cation binding site in herpes simplex virus 1 (HSV-1) ICP8 required for HSV replication</text></passage><passage><infon key="fpage">427</infon><infon key="issue">3</infon><infon key="lpage">436</infon><infon key="name_0">surname:Montgomery;given-names:R. I.</infon><infon key="name_1">surname:Warner;given-names:M. S.</infon><infon key="name_2">surname:Lum;given-names:B. J.</infon><infon key="name_3">surname:Spear;given-names:P. G.</infon><infon key="pub-id_doi">10.1016/S0092-8674(00)81363-X</infon><infon key="pub-id_other">2-s2.0-0030298375</infon><infon key="pub-id_pmid">8898196</infon><infon key="section_type">REF</infon><infon key="source"> Cell </infon><infon key="type">ref</infon><infon key="volume">87</infon><infon key="year">1996</infon><offset>12336</offset><text>Herpes simplex virus-1 entry into cells mediated by a novel member of the TNF/NGF receptor family</text></passage><passage><infon key="name_0">surname:Mortazavi;given-names:H.</infon><infon key="name_1">surname:Nikfar;given-names:B.</infon><infon key="name_2">surname:Esmaeili;given-names:S. A.</infon><infon key="pub-id_doi">10.1016/j.ejmech.2019.111951</infon><infon key="pub-id_pmid">31821990</infon><infon key="section_type">REF</infon><infon key="source"> European Journal of Medicinal Chemistry </infon><infon key="type">ref</infon><infon key="volume">187, article 111951</infon><infon key="year">2020</infon><offset>12434</offset><text>Potential cytotoxic and anti-metastatic effects of berberine on gynaecological cancers with drug-associated resistance</text></passage><passage><infon key="fpage">645</infon><infon key="issue">6</infon><infon key="lpage">657</infon><infon key="name_0">surname:Kupeli;given-names:E.</infon><infon key="name_1">surname:Kosar;given-names:M.</infon><infon key="name_2">surname:Yesilada;given-names:E.</infon><infon key="name_3">surname:Husnu;given-names:K.</infon><infon key="name_4">surname:Baser;given-names:C.</infon><infon key="pub-id_doi">10.1016/S0024-3205(02)02200-2</infon><infon key="pub-id_other">2-s2.0-0037184696</infon><infon key="pub-id_pmid">12467905</infon><infon key="section_type">REF</infon><infon key="source"> Life Sciences </infon><infon key="type">ref</infon><infon key="volume">72</infon><infon key="year">2002</infon><offset>12553</offset><text>A comparative study on the anti-inflammatory, antinociceptive and antipyretic effects of isoquinoline alkaloids from the roots of Turkish Berberis species</text></passage><passage><infon key="fpage">1067</infon><infon key="issue">9</infon><infon key="lpage">1076</infon><infon key="name_0">surname:Amin;given-names:A. H.</infon><infon key="name_1">surname:Subbaiah;given-names:T. V.</infon><infon key="name_2">surname:Abbasi;given-names:K. M.</infon><infon key="pub-id_doi">10.1139/m69-190</infon><infon key="pub-id_other">2-s2.0-0014569720</infon><infon key="pub-id_pmid">4906191</infon><infon key="section_type">REF</infon><infon key="source"> Canadian Journal of Microbiology </infon><infon key="type">ref</infon><infon key="volume">15</infon><infon key="year">1969</infon><offset>12708</offset><text>Berberine sulfate: antimicrobial activity, bioassay, and mode of action</text></passage><passage><infon key="fpage">p. 334</infon><infon key="name_0">surname:Chen;given-names:Q.</infon><infon key="name_1">surname:Mo;given-names:R.</infon><infon key="name_2">surname:Wu;given-names:N.</infon><infon key="pub-id_doi">10.3389/fphar.2017.00334</infon><infon key="pub-id_other">2-s2.0-85020718391</infon><infon key="pub-id_pmid">28634451</infon><infon key="section_type">REF</infon><infon key="source"> Frontiers in Pharmacology </infon><infon key="type">ref</infon><infon key="volume">8</infon><infon key="year">2017</infon><offset>12780</offset><text>Berberine ameliorates diabetes-associated cognitive decline through modulation of aberrant inflammation response and insulin signaling pathway in DM rats</text></passage><passage><infon key="fpage">p. 9</infon><infon key="issue">1</infon><infon key="name_0">surname:Zhu;given-names:L.</infon><infon key="name_1">surname:Han;given-names:J.</infon><infon key="name_2">surname:Yuan;given-names:R.</infon><infon key="name_3">surname:Xue;given-names:L.</infon><infon key="name_4">surname:Pang;given-names:W.</infon><infon key="pub-id_doi">10.1186/s40659-018-0157-8</infon><infon key="pub-id_other">2-s2.0-85046246338</infon><infon key="pub-id_pmid">29604956</infon><infon key="section_type">REF</infon><infon key="source"> Biological Research </infon><infon key="type">ref</infon><infon key="volume">51</infon><infon key="year">2018</infon><offset>12934</offset><text>Berberine ameliorates diabetic nephropathy by inhibiting TLR4/NF-kappaB pathway</text></passage><passage><infon key="fpage">9895</infon><infon key="issue">23</infon><infon key="lpage">9904</infon><infon key="name_0">surname:Zhang;given-names:X.</infon><infon key="name_1">surname:Gu;given-names:L.</infon><infon key="name_2">surname:Li;given-names:J.</infon><infon key="pub-id_doi">10.1158/0008-5472.CAN-10-1546</infon><infon key="pub-id_other">2-s2.0-78649938412</infon><infon key="pub-id_pmid">20935220</infon><infon key="section_type">REF</infon><infon key="source"> Cancer Research </infon><infon key="type">ref</infon><infon key="volume">70</infon><infon key="year">2010</infon><offset>13014</offset><text>Degradation of MDM2 by the interaction between berberine and DAXX leads to potent apoptosis in MDM2-overexpressing cancer cells</text></passage><passage><infon key="fpage">354</infon><infon key="issue">3</infon><infon key="lpage">364</infon><infon key="name_0">surname:Li;given-names:J.</infon><infon key="name_1">surname:Gu;given-names:L.</infon><infon key="name_2">surname:Zhang;given-names:H.</infon><infon key="pub-id_doi">10.1038/labinvest.2012.172</infon><infon key="pub-id_other">2-s2.0-84874591642</infon><infon key="pub-id_pmid">23295648</infon><infon key="section_type">REF</infon><infon key="source"> Laboratory Investigation; A Journal of Technical Methods and Pathology </infon><infon key="type">ref</infon><infon key="volume">93</infon><infon key="year">2013</infon><offset>13142</offset><text>Berberine represses DAXX gene transcription and induces cancer cell apoptosis</text></passage><passage><infon key="fpage">1287</infon><infon key="lpage">1293</infon><infon key="name_0">surname:Wang;given-names:Y.</infon><infon key="name_1">surname:Zhang;given-names:S.</infon><infon key="pub-id_doi">10.1016/j.biopha.2018.04.161</infon><infon key="pub-id_other">2-s2.0-85046156103</infon><infon key="pub-id_pmid">29864910</infon><infon key="section_type">REF</infon><infon key="source"> Biomedicine &amp; Pharmacotherapy = Biomedecine &amp; Pharmacotherapie </infon><infon key="type">ref</infon><infon key="volume">103</infon><infon key="year">2018</infon><offset>13220</offset><text>Berberine suppresses growth and metastasis of endometrial cancer cells via miR-101/COX-2</text></passage><passage><infon key="fpage">385</infon><infon key="issue">3</infon><infon key="lpage">392</infon><infon key="name_0">surname:Kang;given-names:Y. H.</infon><infon key="name_1">surname:Lee;given-names:E.</infon><infon key="name_2">surname:Choi;given-names:M. K.</infon><infon key="pub-id_doi">10.1002/ijc.20424</infon><infon key="pub-id_other">2-s2.0-6344283043</infon><infon key="pub-id_pmid">15382062</infon><infon key="section_type">REF</infon><infon key="source"> International Journal of Cancer </infon><infon key="type">ref</infon><infon key="volume">112</infon><infon key="year">2004</infon><offset>13309</offset><text>Role of reactive oxygen species in the induction of apoptosis by alpha-tocopheryl succinate</text></passage><passage><infon key="fpage">444</infon><infon key="issue">6</infon><infon key="lpage">452</infon><infon key="name_0">surname:Wu;given-names:Y.</infon><infon key="name_1">surname:Li;given-names:J. Q.</infon><infon key="name_2">surname:Kim;given-names:Y. J.</infon><infon key="name_3">surname:Wu;given-names:J.</infon><infon key="name_4">surname:Wang;given-names:Q.</infon><infon key="name_5">surname:Hao;given-names:Y.</infon><infon key="pub-id_doi">10.1007/s11655-011-0640-3</infon><infon key="pub-id_other">2-s2.0-79960135910</infon><infon key="pub-id_pmid">21660679</infon><infon key="section_type">REF</infon><infon key="source"> Chinese Journal of Integrative Medicine </infon><infon key="type">ref</infon><infon key="volume">17</infon><infon key="year">2011</infon><offset>13401</offset><text>In vivo and in vitro antiviral effects of berberine on influenza virus</text></passage><passage><infon key="fpage">65</infon><infon key="issue">1</infon><infon key="lpage">68</infon><infon key="name_0">surname:Shin;given-names:H. B.</infon><infon key="name_1">surname:Choi;given-names:M. S.</infon><infon key="name_2">surname:Yi;given-names:C. M.</infon><infon key="name_3">surname:Lee;given-names:J.</infon><infon key="name_4">surname:Kim;given-names:N. J.</infon><infon key="name_5">surname:Inn;given-names:K. S.</infon><infon key="pub-id_doi">10.1016/j.intimp.2015.04.045</infon><infon key="pub-id_other">2-s2.0-84929072553</infon><infon key="pub-id_pmid">25939536</infon><infon key="section_type">REF</infon><infon key="source"> International Immunopharmacology </infon><infon key="type">ref</infon><infon key="volume">27</infon><infon key="year">2015</infon><offset>13472</offset><text>Inhibition of respiratory syncytial virus replication and virus-induced p38 kinase activity by berberine</text></passage><passage><infon key="fpage">9743</infon><infon key="issue">21</infon><infon key="lpage">9757</infon><infon key="name_0">surname:Varghese;given-names:F. S.</infon><infon key="name_1">surname:Thaa;given-names:B.</infon><infon key="name_2">surname:Amrun;given-names:S. N.</infon><infon key="pub-id_doi">10.1128/JVI.01382-16</infon><infon key="pub-id_other">2-s2.0-84993159425</infon><infon key="pub-id_pmid">27535052</infon><infon key="section_type">REF</infon><infon key="source"> Journal of Virology </infon><infon key="type">ref</infon><infon key="volume">90</infon><infon key="year">2016</infon><offset>13577</offset><text>The antiviral alkaloid berberine reduces chikungunya virus-induced mitogen-activated protein kinase signaling</text></passage><passage><infon key="fpage">p. 2</infon><infon key="issue">1</infon><infon key="name_0">surname:Wang;given-names:H.</infon><infon key="name_1">surname:Li;given-names:K.</infon><infon key="name_2">surname:Ma;given-names:L.</infon><infon key="pub-id_doi">10.1186/s12985-016-0674-4</infon><infon key="pub-id_other">2-s2.0-85009154285</infon><infon key="pub-id_pmid">28081706</infon><infon key="section_type">REF</infon><infon key="source"> Virology Journal </infon><infon key="type">ref</infon><infon key="volume">14</infon><infon key="year">2017</infon><offset>13687</offset><text>Berberine inhibits enterovirus 71 replication by downregulating the MEK/ERK signaling pathway and autophagy</text></passage><passage><infon key="fpage">p. 39</infon><infon key="issue">1</infon><infon key="name_0">surname:Mahata;given-names:S.</infon><infon key="name_1">surname:Bharti;given-names:A. C.</infon><infon key="name_2">surname:Shukla;given-names:S.</infon><infon key="name_3">surname:Tyagi;given-names:A.</infon><infon key="name_4">surname:Husain;given-names:S. A.</infon><infon key="name_5">surname:Das;given-names:B. C.</infon><infon key="pub-id_doi">10.1186/1476-4598-10-39</infon><infon key="pub-id_other">2-s2.0-79955085632</infon><infon key="pub-id_pmid">21496227</infon><infon key="section_type">REF</infon><infon key="source"> Molecular Cancer </infon><infon key="type">ref</infon><infon key="volume">10</infon><infon key="year">2011</infon><offset>13795</offset><text>Berberine modulates AP-1 activity to suppress HPV transcription and downstream signaling to induce growth arrest and apoptosis in cervical cancer cells</text></passage><passage><infon key="fpage">5068</infon><infon key="issue">9</infon><infon key="lpage">5078</infon><infon key="name_0">surname:Song;given-names:S.</infon><infon key="name_1">surname:Qiu;given-names:M.</infon><infon key="name_2">surname:Chu;given-names:Y.</infon><infon key="pub-id_doi">10.1128/AAC.02427-14</infon><infon key="pub-id_other">2-s2.0-84906081424</infon><infon key="pub-id_pmid">24913175</infon><infon key="section_type">REF</infon><infon key="source"> Antimicrobial Agents and Chemotherapy </infon><infon key="type">ref</infon><infon key="volume">58</infon><infon key="year">2014</infon><offset>13947</offset><text>Downregulation of cellular c-Jun N-terminal protein kinase and NF-kappaB activation by berberine may result in inhibition of herpes simplex virus replication</text></passage><passage><infon key="fpage">1149</infon><infon key="issue">3</infon><infon key="lpage">1155</infon><infon key="name_0">surname:Chang;given-names:J. S.</infon><infon key="name_1">surname:Wang;given-names:K. C.</infon><infon key="name_2">surname:Shieh;given-names:D. E.</infon><infon key="name_3">surname:Chiang;given-names:L. C.</infon><infon key="pub-id_doi">10.1016/j.jep.2011.07.043</infon><infon key="pub-id_other">2-s2.0-80054955049</infon><infon key="pub-id_pmid">21810459</infon><infon key="section_type">REF</infon><infon key="source"> Journal of Ethnopharmacology </infon><infon key="type">ref</infon><infon key="volume">137</infon><infon key="year">2011</infon><offset>14105</offset><text>Liu-He-Tang inhibited plaque formation by human respiratory syncytial virus infection in cell lines of the human respiratory tract</text></passage><passage><infon key="issue">3, article e21423</infon><infon key="name_0">surname:Dong;given-names:S. M.</infon><infon key="name_1">surname:Cui;given-names:J. H.</infon><infon key="name_2">surname:Zhang;given-names:W.</infon><infon key="pub-id_doi">10.1002/arch.21423</infon><infon key="pub-id_other">2-s2.0-85030157917</infon><infon key="pub-id_pmid">28940716</infon><infon key="section_type">REF</infon><infon key="source"> Archives of Insect Biochemistry and Physiology </infon><infon key="type">ref</infon><infon key="volume">96</infon><infon key="year">2017</infon><offset>14236</offset><text>Inhibition of translation initiation factor eIF4A is required for apoptosis mediated by Microplitis bicoloratus bracovirus</text></passage><passage><infon key="fpage">205</infon><infon key="issue">1</infon><infon key="lpage">212</infon><infon key="name_0">surname:Nakai;given-names:K.</infon><infon key="name_1">surname:Karita;given-names:S.</infon><infon key="name_2">surname:Igarashi;given-names:J.</infon><infon key="name_3">surname:Tsukamoto;given-names:I.</infon><infon key="name_4">surname:Hirano;given-names:K.</infon><infon key="name_5">surname:Kubota;given-names:Y.</infon><infon key="pub-id_doi">10.1016/j.jdermsci.2019.02.003</infon><infon key="pub-id_other">2-s2.0-85063729722</infon><infon key="pub-id_pmid">30954335</infon><infon key="section_type">REF</infon><infon key="source"> Journal of Dermatological Science </infon><infon key="type">ref</infon><infon key="volume">94</infon><infon key="year">2019</infon><offset>14359</offset><text>COA-Cl prevented TGF-beta1-induced CTGF expression by Akt dephosphorylation in normal human dermal fibroblasts, and it attenuated skin fibrosis in mice models of systemic sclerosis</text></passage><passage><infon key="issue">3</infon><infon key="name_0">surname:Watanabe;given-names:M.</infon><infon key="name_1">surname:Arii;given-names:J.</infon><infon key="name_2">surname:Takeshima;given-names:K.</infon><infon key="pub-id_doi">10.1128/JVI.01413-20</infon><infon key="pub-id_pmid">33177205</infon><infon key="section_type">REF</infon><infon key="source"> Journal of Virology </infon><infon key="type">ref</infon><infon key="volume">95</infon><infon key="year">2021</infon><offset>14540</offset><text>Prohibitin-1 contributes to cell-to-cell transmission of herpes simplex virus 1 via the MAPK/ERK signaling pathway</text></passage><passage><infon key="fpage">937</infon><infon key="issue">7</infon><infon key="lpage">947</infon><infon key="name_0">surname:Sufiawati;given-names:I.</infon><infon key="name_1">surname:Tugizov;given-names:S. M.</infon><infon key="pub-id_doi">10.1099/jgv.0.001075</infon><infon key="pub-id_other">2-s2.0-85049860354</infon><infon key="pub-id_pmid">29775175</infon><infon key="section_type">REF</infon><infon key="source"> The Journal of General Virology </infon><infon key="type">ref</infon><infon key="volume">99</infon><infon key="year">2018</infon><offset>14655</offset><text>HIV-induced matrix metalloproteinase-9 activation through mitogen-activated protein kinase signalling promotes HSV-1 cell-to-cell spread in oral epithelial cells</text></passage><passage><infon key="issue">9</infon><infon key="name_0">surname:Dhanushkodi;given-names:N. R.</infon><infon key="name_1">surname:Srivastava;given-names:R.</infon><infon key="name_2">surname:Prakash;given-names:S.</infon><infon key="pub-id_doi">10.1128/JVI.00140-20</infon><infon key="pub-id_pmid">32102882</infon><infon key="section_type">REF</infon><infon key="source"> Journal of Virology </infon><infon key="type">ref</infon><infon key="volume">94</infon><infon key="year">2020</infon><offset>14817</offset><text>High frequency of gamma interferon-producing PLZFloRORgammatloInvariant natural killer 1 cells infiltrating herpes simplex virus 1-infected corneas is associated with asymptomatic ocular herpesvirus infection</text></passage><passage><infon key="issue">2</infon><infon key="name_0">surname:Tormanen;given-names:K.</infon><infon key="name_1">surname:Wang;given-names:S.</infon><infon key="name_2">surname:Ghiasi;given-names:H.</infon><infon key="pub-id_doi">10.1128/JVI.01511-19</infon><infon key="pub-id_pmid">31619558</infon><infon key="section_type">REF</infon><infon key="source"> Journal of Virology </infon><infon key="type">ref</infon><infon key="volume">94</infon><infon key="year">2020</infon><offset>15026</offset><text>CD80 plays a critical role in increased inflammatory responses in herpes simplex virus 1-infected mouse corneas</text></passage><passage><infon key="fpage">1635</infon><infon key="issue">13</infon><infon key="lpage">1652</infon><infon key="name_0">surname:Kukhanova;given-names:M. K.</infon><infon key="name_1">surname:Korovina;given-names:A. N.</infon><infon key="name_2">surname:Kochetkov;given-names:S. N.</infon><infon key="pub-id_doi">10.1134/S0006297914130124</infon><infon key="pub-id_other">2-s2.0-84920571003</infon><infon key="pub-id_pmid">25749169</infon><infon key="section_type">REF</infon><infon key="source"> Biochemistry Biokhimiia </infon><infon key="type">ref</infon><infon key="volume">79</infon><infon key="year">2014</infon><offset>15138</offset><text>Human herpes simplex virus: life cycle and development of inhibitors</text></passage><passage><infon key="fpage">82</infon><infon key="lpage">90</infon><infon key="name_0">surname:Li;given-names:W.</infon><infon key="name_1">surname:Yin;given-names:N.</infon><infon key="name_2">surname:Tao;given-names:W.</infon><infon key="name_3">surname:Wang;given-names:Q.</infon><infon key="name_4">surname:Fan;given-names:H.</infon><infon key="name_5">surname:Wang;given-names:Z.</infon><infon key="pub-id_doi">10.1016/j.intimp.2018.11.009</infon><infon key="pub-id_other">2-s2.0-85056466941</infon><infon key="pub-id_pmid">30445310</infon><infon key="section_type">REF</infon><infon key="source"> International Immunopharmacology </infon><infon key="type">ref</infon><infon key="volume">66</infon><infon key="year">2019</infon><offset>15207</offset><text>Berberine suppresses IL-33-induced inflammatory responses in mast cells by inactivating NF-kappaB and p38 signaling</text></passage><passage><infon key="fpage">91</infon><infon key="lpage">97</infon><infon key="name_0">surname:Gao;given-names:L.</infon><infon key="name_1">surname:Schmitz;given-names:H. J.</infon><infon key="name_2">surname:Merz;given-names:K. H.</infon><infon key="name_3">surname:Schrenk;given-names:D.</infon><infon key="pub-id_doi">10.1016/j.toxlet.2019.04.031</infon><infon key="pub-id_other">2-s2.0-85065167848</infon><infon key="pub-id_pmid">31054355</infon><infon key="section_type">REF</infon><infon key="source"> Toxicology Letters </infon><infon key="type">ref</infon><infon key="volume">311</infon><infon key="year">2019</infon><offset>15323</offset><text>Characterization of the cytotoxicity of selected _Chelidonium_ alkaloids in rat hepatocytes</text></passage><passage><infon key="fpage">487</infon><infon key="issue">4</infon><infon key="lpage">501</infon><infon key="name_0">surname:Belanova;given-names:A.</infon><infon key="name_1">surname:Beseda;given-names:D.</infon><infon key="name_2">surname:Chmykhalo;given-names:V.</infon><infon key="pub-id_doi">10.2174/1871520619666181211121405</infon><infon key="pub-id_other">2-s2.0-85069534999</infon><infon key="pub-id_pmid">30526471</infon><infon key="section_type">REF</infon><infon key="source"> Anti-Cancer Agents in Medicinal Chemistry </infon><infon key="type">ref</infon><infon key="volume">19</infon><infon key="year">2019</infon><offset>15415</offset><text>Berberine effects on NFkappaB, HIF1A and NFE2L2/AP-1 pathways in HeLa cells</text></passage><passage><infon key="fpage">1933</infon><infon key="issue">12</infon><infon key="lpage">1941</infon><infon key="name_0">surname:Chin;given-names:L. W.</infon><infon key="name_1">surname:Cheng;given-names:Y. W.</infon><infon key="name_2">surname:Lin;given-names:S. S.</infon><infon key="pub-id_doi">10.1007/s00705-010-0779-9</infon><infon key="pub-id_other">2-s2.0-78449281656</infon><infon key="pub-id_pmid">20686799</infon><infon key="section_type">REF</infon><infon key="source"> Archives of Virology </infon><infon key="type">ref</infon><infon key="volume">155</infon><infon key="year">2010</infon><offset>15491</offset><text>Anti-herpes simplex virus effects of berberine from Coptidis rhizoma, a major component of a Chinese herbal medicine, Ching-Wei-San</text></passage><passage><infon key="fpage">1448</infon><infon key="lpage">1455</infon><infon key="name_0">surname:Dai;given-names:Q.</infon><infon key="name_1">surname:Zhang;given-names:D.</infon><infon key="name_2">surname:Yu;given-names:H.</infon><infon key="pub-id_doi">10.12659/MSM.899804</infon><infon key="pub-id_other">2-s2.0-85018475648</infon><infon key="pub-id_pmid">28341822</infon><infon key="section_type">REF</infon><infon key="source"> Medical Science Monitor </infon><infon key="type">ref</infon><infon key="volume">23</infon><infon key="year">2017</infon><offset>15623</offset><text>Berberine restricts coxsackievirus B type 3 replication via inhibition of c-Jun N-terminal kinase (JNK) and p 38 MAPK activation in vitro</text></passage><passage><infon key="name_0">surname:Zeng;given-names:Q. X.</infon><infon key="name_1">surname:Wang;given-names:H. Q.</infon><infon key="name_2">surname:Wei;given-names:W.</infon><infon key="pub-id_doi">10.1016/j.bioorg.2019.103490</infon><infon key="pub-id_pmid">31855821</infon><infon key="section_type">REF</infon><infon key="source"> Bioorganic Chemistry </infon><infon key="type">ref</infon><infon key="volume">95, article 103490</infon><infon key="year">2020</infon><offset>15761</offset><text>Synthesis and biological evaluation of berberine derivatives as a new class of broad-spectrum antiviral agents against coxsackievirus B</text></passage><passage><infon key="file">CMMM2022-7137401.001.jpg</infon><infon key="id">fig1</infon><infon key="section_type">FIG</infon><infon key="type">fig_caption</infon><offset>15897</offset><text>Berberine antagonizes HSV-1 infection in HEK293T cells. (a) Berberine chemical structure. (b) CCK-8 assay was performed to explore berberine CC50 in HEK293T cells. (c) Plaque reduction assay was carried out to explore berberine IC50 in HEK293T cells. (d) Plaque reduction assay was performed to assess the effect of berberine on HSV-1 plaque formation in HEK293T cells. All data are presented as the means +- SD.</text></passage><passage><infon key="file">CMMM2022-7137401.002.jpg</infon><infon key="id">fig2</infon><infon key="section_type">FIG</infon><infon key="type">fig_caption</infon><offset>16310</offset><text>Berberine decreases HSV-1 activity in HEK293T cells. (a) RT-qPCR was performed to assess the mRNA levels of HSV-1-related genes, including gD, ICP4, ICP5, and ICP8. (b) Western blot was performed to measure the protein levels of gD, ICP4, ICP5, and ICP8. All data are presented as the means +- SD. **P &lt; 0.01vs. control group, #P &lt; 0.05vs. HSV group,  P &lt; 0.05vs. HSV+5 muM group, and +P &lt; 0.05vs. HSV+10 muM group.</text></passage><passage><infon key="file">CMMM2022-7137401.003.jpg</infon><infon key="id">fig3</infon><infon key="section_type">FIG</infon><infon key="type">fig_caption</infon><offset>16736</offset><text>Berberine inhibits JNK and p38 activation induced by HSV-1 infection. Western blot was performed to assess the protein levels of p-JNK, JNK, p-p38, p38, and beta-actin in HEK293T cells. All data are presented as the means +- SD. **P &lt; 0.01 and***P &lt; 0.001vs. control group, #P &lt; 0.05vs. HSV group,  P &lt; 0.05vs. HSV+5 muM group, and +P &lt; 0.05vs. HSV+10 muM group.</text></passage><passage><infon key="file">CMMM2022-7137401.004.jpg</infon><infon key="id">fig4</infon><infon key="section_type">FIG</infon><infon key="type">fig_caption</infon><offset>17115</offset><text>Berberine decreases inflammatory response induced by HSV-1 infection. (a) RT-qPCR analysis was performed to assess the mRNA levels of inflammatory cytokines, including IL-1beta, IL-6, TNF-alpha, and IL-8 in HEK293T cells. (b) ELISA assay was carried out to assay IL-1beta, IL-6, TNF-alpha, and IL-8 expression in HEK293T cell supernatant. All data are presented as the means +- SD. **P &lt; 0.01 and***P &lt; 0.001vs. control group, #P &lt; 0.05vs. HSV group,  P &lt;0.05 vs. HSV+5 muM group, and +P &lt; 0.05 vs. HSV+10 muM group.</text></passage></document> 
</collection>
